Literature DB >> 24231626

Cetuximab and non-small-cell lung cancer: end of the story?

Antonio Rossi1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24231626     DOI： 10.1016/S1470-2045(13)70498-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.

Authors:  Austin Lammers; Christopher G Slatore; Erik K Fromme; Kelly C Vranas; Donald R Sullivan
Journal:  J Thorac Oncol       Date:  2018-10-15       Impact factor: 15.609

Review 2.  Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond.

Authors:  Christopher Delaney; Samuel Frank; R Stephanie Huang
Journal:  Chin J Cancer       Date:  2015-04-08

3.  Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.

Authors:  Rita De Santis; Antonio Rosi; Anna Maria Anastasi; Caterina Chiapparino; Claudio Albertoni; Barbara Leoni; Angela Pelliccia; Daniela Santapaola; Valeria Carollo; Emanuele Marra; Luigi Aurisicchio; Brunilde Arseni; Maria Lucrezia Pacello; Gabriella Palmieri; Simone Battella; Fiorella Petronzelli; Ferdinando Maria Milazzo
Journal:  Oncotarget       Date:  2014-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.